We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
West’s Fran DeGrazio, Vice President, Global Research and Development, will present, “QbD for Elastomeric Components – A Case Study” with Mihaela Simianu, Research Advisor, Manufacturing Science, Eli Lilly and Company, on Tuesday, May 14 at 10:30 a.m. at the 2013 PDA/FDA Container Closure Components and Systems Workshop.
The one-and-a-half day workshop will tie together a broad scope of attributes for container closure systems and the potential impact to quality of therapies from the point of component selection, to the manufacture of medicine and delivery to the patient. Discussion will touch upon packaging materials, components, delivery systems, human factors, supply chain and Quality by Design.
West’s Diane Paskiet co-chairs the program. Additional speakers include:
Prior to the workshop, PDA’s Training and Research Institute (PDA TRI) will hold the Essential Elements of Extractables & Leachables: From Material Selection to Final Report course. This course will demonstrate through examples and case studies the essential elements of the extractables and leachables process from the selection and evaluation of packaging materials to the writing of the study report – conversion of data to information.
For more information or to register, visit www.pda.org/containerclosure2013
Our team will share their expertise and introduce several new and innovative pharmaceutical containment and closure offerings during the Paris Pharmapack trade show.
In March, West presented the Sri Shankara Cancer Hospital with a donation at the opening of West Digital Technology Center (DTC) in Bengaluru, India. These funds will support patients who need financial assistance and who would otherwise not be able to afford their cancer treatment.
Particles in parenteral drug products continue to be an important concern. At the April-2017 AAPS Workshop <strong>Challenges and Patient Impact of Particles in Biologics</strong>, Fran DeGrazio, VP of Scientific Affairs and Technical Services, spoke on the topic: <em>Unique Considerations for Testing and Understanding Particle Loads for Primary Packaging Components.</em> <br />
Twelve weeks, 60 days, or 480 hours is all that I have in the summer of 2014 to showcase my talents as the Pharmaceutical Delivery Systems (PDS) Marketing and Innovation Ambassador Intern. To many, that might seem to be a rather extensive amount of time to become familiar with an organization, meet respective colleagues, learn about products and operations, and develop a means to an end for the designated project assignment that all Ambassadors receive every summer.
<p style="margin: 0in 0in 0pt;"><span>Every day, all day, safety matters. Safety never takes a day off. All around us we see safety warnings such as allergens on food labels, use-by-dates on milk and expiration dates on medications. There is no substitute for doing things safely. For pharmaceutical and biotechnology companies offering parenteral drug products, patient safety is the utmost concern.</span></p>
English
Chinese
